tiprankstipranks
Bio-Rad now sees non-GAAP revenue for FY down 1% to up 1.5%
PremiumThe FlyBio-Rad now sees non-GAAP revenue for FY down 1% to up 1.5%
2M ago
Bio-Rad reports Q1 EPS $2.54, consensus $1.78
Premium
The Fly
Bio-Rad reports Q1 EPS $2.54, consensus $1.78
2M ago
Is BIO a Buy, Before Earnings?
Premium
Pre-Earnings
Is BIO a Buy, Before Earnings?
2M ago
Bio-Rad Laboratories Reports 2024 Earnings and Strategic Plans
PremiumCompany AnnouncementsBio-Rad Laboratories Reports 2024 Earnings and Strategic Plans
4M ago
Bio-Rad reports Q4 adjusted EPS $2.90, consensus $2.88
Premium
The Fly
Bio-Rad reports Q4 adjusted EPS $2.90, consensus $2.88
4M ago
Bio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%
Premium
The Fly
Bio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%
4M ago
Bio-Rad price target raised to $469 from $446 at RBC Capital
PremiumThe FlyBio-Rad price target raised to $469 from $446 at RBC Capital
8M ago
Bio-Rad price target raised to $450 from $400 at Citi
Premium
The Fly
Bio-Rad price target raised to $450 from $400 at Citi
8M ago
Bio-Rad Laboratories Reports Q3 2024 Earnings Growth
Premium
Company Announcements
Bio-Rad Laboratories Reports Q3 2024 Earnings Growth
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100